Structures by: Antipin M.
Total: 7
C12H19EuN2O10,H2O
C12H19EuN2O10,H2O
Dalton transactions (Cambridge, England : 2003) (2007) 36 4079-4088
a=15.4180(10)Å b=8.4575(5)Å c=26.0158(17)Å
α=90.00° β=90.6985(12)° γ=90.00°
C28H34EuN8O10,4(H2O),Cl
C28H34EuN8O10,4(H2O),Cl
Dalton transactions (Cambridge, England : 2003) (2007) 36 4079-4088
a=7.2681(19)Å b=20.816(5)Å c=23.403(6)Å
α=90.00° β=90.00° γ=90.00°
C22H18Br2O2
C22H18Br2O2
Chem.Commun. (2012) 48, 10416
a=7.1515(13)Å b=10.698(2)Å c=24.150(4)Å
α=90.00° β=90.00° γ=90.00°
C22H16Br2O3
C22H16Br2O3
Chem.Commun. (2012) 48, 10416
a=18.738(7)Å b=11.950(5)Å c=16.831(7)Å
α=90.00° β=93.958(9)° γ=90.00°
2(C22H18Br2O2),CHCl3
2(C22H18Br2O2),CHCl3
Chem.Commun. (2012) 48, 10416
a=9.0997(12)Å b=13.8505(18)Å c=16.388(2)Å
α=90.673(2)° β=96.255(2)° γ=96.812(2)°
Narciclasine hemihydrate
C14H13NO7,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 1 o9-o10
a=10.90063(8)Å b=20.37357(17)Å c=11.88385(9)Å
α=90.00° β=104.3549(8)° γ=90.00°
Bis(pyridine-4-carboxaldehyde) fumaric acid
2(C6H5NO),C4H4O4
Acta Crystallographica Section E (2013) 69, 6 o940
a=6.9388(12)Å b=10.1962(18)Å c=17.002(3)Å
α=82.450(3)° β=78.615(3)° γ=80.064(3)°